TOKYO -- Japan is set to host the world's first clinical trials involving the use of induced pluripotent stem (iPS) cells to treat heart failure.
Science
Japan approves first trials of stem cell-based heart treatment
iPS procedure raises hopes for alternative to donations and artificial organs
